Tailoring Treatment of EGFR-Mutated NSCLC: Pharmacy Perspectives to Improve Patient Care

Watch an on-demand Webcast and download slidesets from our HOPA 2018 and AMCP Nexus 2018 symposia where expert faculty review key developments on EGFR-targeted therapies for advanced EGFR-mutated NSCLC and share their perspectives on how pharmacists can safely and effectively apply these new practice-changing data into care plans for their patients.

Share

Program Content

Activities

<i>EGFR</i>-Mut NSCLC and EGFR TKIs
Overview of EGFR-Mutated NSCLC and Pharmacology of EGFR TKIs
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 02, 2018

Expires: March 01, 2019

Therapy Selection for <i>EGFR</i>-Mut NSCLC
Selecting First-line and Second-line Therapy in the Setting of EGFR Mutation–Positive NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 02, 2018

Expires: March 01, 2019

<i>EGFR</i>-Mut NSCLC: Pharmacy Perspectives
Improving Patient Outcomes and Providing Cost-Effective Care in EGFR-Mutated NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 02, 2018

Expires: March 01, 2019

Activities

Pharmacy in <i>EGFR</i>mut NSCLC
Tailoring Treatment of EGFR-Mutated NSCLC: Pharmacy Perspectives to Improve Patient Care
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: April 23, 2018

Expires: April 22, 2019

Faculty

cover img faculity

Val R. Adams, PharmD, FCCP, BCOP

Associate Professor
Department of Pharmacy Practice and Science
University of Kentucky
Lexington, Kentucky

cover img faculity

Heather J. Jackson, PhD, FNP-BC, NEA-BC, FAANP

Associate Professor
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University School of Nursing
Administrative Director of Advanced Practice
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

cover img faculity

Edward S. Kim, MD

Chief, Section of Head and Neck Medical Oncology
Associate Professor, Thoracic/Head and Neck Medical Oncology
University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Philip Schwieterman, PharmD, MHA

Director of Oncology and Pediatric Pharmacy
Markey Cancer Center
UK Health Care
Lexington, Kentucky

cover img faculity

H. Jack West, MD

Medical Director
Thoracic Oncology Program
Swedish Cancer Institute
Seattle, Washington

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

AstraZeneca